Adenocarcinoma of Lung Stage IV Active Not Recruiting Phase 1 Trials for Certolizumab pegol (DB08904)

Also known as: Adenocarcinoma Lung Stage IV / Lung adenocarcinoma stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV

IndicationStatusPhase
DBCOND0062752 (Adenocarcinoma of Lung Stage IV)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02120807Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung AdenocarcinomasTreatment